Business Context and Reporting Period
Company: Texas Instruments Incorporated (TI)
Filing Type: Form 10-Q
Reporting Period: Quarter ended March 31, 2004
Business Overview: TI designs, manufactures, and sells high-technology components and systems across three segments: Semiconductor (85% of 2003 revenue), Sensors & Controls (10%), and Educational & Productivity Solutions (5%). The Semiconductor segment focuses on Analog semiconductors and Digital Signal Processors (DSPs).
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Revenue | $2,936 | $2,192 |
| Gross Profit | $1,322 | $862 |
| Gross Margin | 45.0% | 39.3% |
| Operating Profit | $474 | $153 |
| Operating Margin | 16.2% | 7.0% |
| Net Income | $367 | $117 |
| Diluted EPS | $0.21 | $0.07 |
| Cash Flow from Operations | $393 | $196 |
| Total Cash & Investments | $5,493 | N/A |
| Debt-to-Total-Capital Ratio | 0.06 | 0.09 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 34% year-over-year (YoY) and 6% sequentially, driven primarily by the Semiconductor segment (+38% YoY). Growth was fueled by demand for DLP products, high-performance analog, and wireless applications.
- Profitability Expansion: Operating profit surged 203% YoY to $474 million. Gross margin expanded 5.7 percentage points YoY to 45.0%, benefiting from higher utilization of fixed-cost manufacturing assets.
- Expense Increases: R&D expenses rose 21% YoY ($494 million) due to increased product development and profit-sharing accruals. SG&A expenses increased 18% YoY ($354 million).
- Other Income: Other income (expense) net was $50 million, a decrease from the prior quarter due to the absence of a $97 million gain from the sale of Micron Technology stock recorded in Q4 2003.
- Restructuring: TI recorded $5 million in restructuring charges in Q1 2004 ($2 million in Semiconductor, $3 million in Sensors & Controls), primarily for severance and benefits.
Guidance, Outlook, and Risks
- Outlook: Management expects 2004 to be a strong year with continued revenue growth and higher operating margins. The company recorded a profit-sharing accrual for the first time since 2000, estimating approximately $70 million per quarter for the remainder of the year.
- Capital Allocation: TI plans to invest approximately $2.1 billion in R&D and $1.3 billion in capital expenditures for 2004. This includes adding a 90-nanometer manufacturing line and expanding assembly/test capacity.
- Stock Repurchases: The company repurchased 5.6 million shares for $172 million in Q1 2004 to offset dilution from stock options. Approximately 24.9 million shares remain available under current authorization.
- Risks and Contingencies:
- Italian Government Grants: Auditors are reviewing ~$250 million in grants to TI's former Italian memory operations. While TI believes it is in compliance, a portion may be demanded for repayment. Management does not expect a material impact.
- Medicare Act: TI is evaluating the impact of the Medicare Prescription Drug Improvement and Modernization Act of 2003 on its postretirement benefit obligations.
- Market Volatility: The semiconductor industry is cyclical and competitive. Risks include customer inventory adjustments, supply chain disruptions, and rapid technological changes.
Investor Verification Checklist
- Wireless Customer Concentration: Verify the impact of production adjustments by TI's largest wireless customer on future quarterly shipments.
- Profit Sharing Accruals: Monitor the quarterly profit-sharing accruals (~$70M) as a variable cost that could impact margins if full-year performance estimates change.
- Inventory Levels: Days of inventory increased to 64 days (from 56 days prior quarter); verify if this buildup aligns with anticipated demand or signals potential slowdown.
- Restructuring Completion: Track the remaining $48 million in restructuring accruals and the timeline for payments (expected through 2005-2008 for prior actions).
- Italian Grant Resolution: Monitor the final decision by the Italian Ministry of Industry regarding the $250 million grant review.